Pacific Biosciences of California (PACB) Stock Price
$1.54 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
2 -
Technical
7
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Pacific Biosciences of California, AI stock picks, stock alerts and much more.
PACB AI Stock Analysis
AI stock analysis for PACB is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Pacific Biosciences of California (PACB) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Pacific Biosciences of California (PACB) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Pacific Biosciences of California (PACB), currently trading at $1.54, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About PACB
-
Pacific Biosciences of California, Inc.
-
Symbol
PACB
-
Market
NASDAQ
-
Industry
Medical - Devices
-
Market Cap
421.8M
Similar Stocks
 |
Align Technology ALGN |
$190.4 3.9% |
5 |
 |
iRhythm Technologies IRTC |
$119.4 6% |
6 |
 |
Cutera CUTR |
$0.43 5.3% |
4 |
 |
Dexcom DXCM |
$88.78 0.6% |
5 |
 |
Bruker BRKR |
$50.82 4% |
5 |
News
PACB Alternative Data
Web Traffic
Pacific Biosciences of California receives an estimated 101369 monthly visitors to pacb.com.
-
Web Traffic
101369
-
Change from Previous Month
17.4%
-
3 Month Change
8%
-
YoY Change
8%
News Mentions
Pacific Biosciences of California was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Pacific Biosciences of California has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
Twitter Followers
Pacific Biosciences of California has 45,174 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.7% over the last month.
-
Twitter Followers
45174
-
Daily Change
0%
-
1 Month Change
0.7%
-
3 Month Change
1%
-
YoY Change
1%
Facebook Engagement
Pacific Biosciences of California has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
-
YoY Change
100%
Youtube Subscribers
Pacific Biosciences of California has 5,820 subscribers on its main Youtube channel, up by 0.9% over the last month.
-
Youtube Subscribers
5820
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
2.3%
-
YoY Change
2.3%
LinkedIn Followers
81,758 are following Pacific Biosciences of California on LinkedIn, up by 1.6% over the last month.
-
LinkedIn Followers
81758
-
Daily Change
0%
-
1 Month Change
1.6%
-
3 Month Change
3.9%
Job Postings
Pacific Biosciences of California currenly has an estimated 25 open job postings, up by 19% over the last month.
-
Job Postings
25
-
Daily Change
0%
-
1 Month Change
19%
-
3 Month Change
47.1%
-
YoY Change
47.1%
LinkedIn Employees
According to LinkedIn, Pacific Biosciences of California has 682 employees, up by 1% over the last month.
-
LinkedIn Employees
682
-
Daily Change
0%
-
1 Month Change
1%
-
3 Month Change
0.6%
-
YoY Change
0.6%
Business Outlook
-
Business Outlook
19
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
PACB Financials
PACB Key Metrics
-
Total Revenue
$40M
-
Net Income
-$60.7M
-
Earnings per Share
-$0.22
-
Free cash flow
-$44.7M
-
EBITDA
-$41.1M
-
EBITDA Ratio
-1.02805
-
Total Assets
$1.5B
PACB 2-year Revenue & Income
PACB 2-year Free Cash Flow
PACB Technicals
PACB SMA
PACB RSI
FAQ
What's the current price of Pacific Biosciences of California (PACB) Stock?
The price of an Pacific Biosciences of California (PACB) share is $1.54.
What's the market cap of Pacific Biosciences of California?
The current market cap of Pacific Biosciences of California is 421.8M.
Should I buy or sell PACB?
Pacific Biosciences of California shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Pacific Biosciences of California is better viewed as a hold or accumulate position while waiting for further developments.
Is Pacific Biosciences of California a good investment?
The current analysis of Pacific Biosciences of California's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Pacific Biosciences of California's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Pacific Biosciences of California (PACB) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Pacific Biosciences of California stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Pacific Biosciences of California (PACB) that investors often compare it to?
Pacific Biosciences of California (PACB) is often compared to similar stocks such as Align Technology, iRhythm Technologies, Cutera, Dexcom and Bruker.
What is the forecast for Pacific Biosciences of California's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Pacific Biosciences of California's stock price to be around $1.53 in 2026. Starting from the current price of $1.54, this represents a 0.5% change in price, indicating a neutral outlook for the stock.
How to buy Pacific Biosciences of California (PACB) Stock?
Pacific Biosciences of California stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Pacific Biosciences of California shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.